[ 3 ] Rudan L, Boschi-Pinto C, Biloglav Z, et al. Epidenmiology and etiology of childhood pneumonia[J]. Bull World Health Organ, 2008, 86(5): 408-416.
[2]
[ 4 ] Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin-Illinois, 1999[J]. MMWR Morb Mortal Wkly Rep, 2000, 48(51-52): 1165-1167.
[ 9 ] Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin-United States, 2002[J]. MMWR Morb Mortal Wkly Rep, 2002, 51(26): 565-567.
[8]
Centers for Disease Control and Prevention. Brief report: vancomycin resistant Staphylococcus aureus New York, 2004[J]. MorbMortal Wkly Rep, 2004, 53(15): 322-323.
[9]
李家泰, Weinstein A, 杨敏, 等. 中国细菌耐药监测研究[J]. 中华医学杂志, 2001, 81(1): 11-19.
[10]
B?swald M, D?big C, K?ndler C, et al. Pharmacokinetic and clinical evaluation of serious infections in premature and newborn infants under therapy with imipenem/cilastatin[J]. Infection, 27(4/5): 299-304.